Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 1/20 | 0.53 |
| ▸ | MET | P08581 | 17/20 | 0.51 |
| ▸ | BRAF | P15056 | 2/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.51 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4822297 | 0.88 | MET (0.59) | MET | |
| SCHEMBL4820065 | 0.88 | MET (0.55) | FLT3METKDR | |
| SCHEMBL4814708 | 0.86 | MET (0.54) | FLT3METBRAFKDRMAPK14 | |
| SCHEMBL4820160 | 0.86 | MET (0.53) | FLT3MET | |
| SCHEMBL4820012 | 0.86 | MET (0.61) | FLT3METKDR | |
| SCHEMBL4820846 | 0.85 | MET (0.51) | FLT3METKDR | |
| SCHEMBL4819186 | 0.85 | MET (0.56) | FLT3METKDR | |
| SCHEMBL4818108 | 0.85 | MET (0.52) | MET | |
| SCHEMBL4818374 | 0.85 | MET (0.67) | FLT3METKDR | |
| SCHEMBL4814790 | 0.85 | MET (0.57) | FLT3METKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439246-B2 | Fused heterocyclic kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-10-21 | — | — | US | claimed |
| US-7439246-B2 | Fused heterocyclic kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-10-21 | — | — | US | disclosed |
| US-7173031-B2 | Pyrrolotriazine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-02-06 | — | — | US | disclosed |